BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8683254)

  • 1. Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option?
    Culine S; Droz JP
    J Clin Oncol; 1996 Jul; 14(7):2187-8. PubMed ID: 8683254
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
    Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
    J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role?
    Motzer RJ
    Semin Urol Oncol; 1996 Feb; 14(1):30-3. PubMed ID: 8833386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.
    Kondagunta GV; Motzer RJ
    Semin Urol Oncol; 2002 Nov; 20(4):239-43. PubMed ID: 12489056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
    Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer. the Indiana University experience.
    Behnia M; Foster R; Einhorn LH; Donohue J; Nichols CR
    Eur J Cancer; 2000 Mar; 36(4):472-5. PubMed ID: 10717522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical stage I non-seminomas. Europe versus USA. A draw.
    Keizer HJ
    Eur J Cancer; 2000 Mar; 36(4):440-2. PubMed ID: 10717517
    [No Abstract]   [Full Text] [Related]  

  • 12. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment.
    Weissbach L; Bussar-Maatz R; Flechtner H; Pichlmeier U; Hartmann M; Keller L
    Eur Urol; 2000 May; 37(5):582-94. PubMed ID: 10765098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current therapeutic orientation toward testicular germ cell tumors].
    Catani M; De Milito R; Chiaretti M; Cortesi E; Anselmi W; Manili G; Tomei B; Terrinoni V; Bianchi G; Rengo M
    Minerva Urol Nefrol; 1999 Jun; 51(2):113-7. PubMed ID: 10429422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor-risk testicular cancer and high-dose chemotherapy.
    Motzer RJ; Sheinfeld S
    J Clin Oncol; 2003 Nov; 21(22):4073-4. PubMed ID: 14568986
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung residuals following chemotherapy in patients with stage III nonseminomatous testicular cancer. Report of 4 cases].
    Ueda T; Yamauchi T; Kawai T; Ohno Y; Kawakami S; Yonese J; Tachibana Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):350-3. PubMed ID: 7509890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular tumor--retroperitoneal lymph node excision successful in patients with stage I nonseminomatous cancer with or without vascular invasion].
    Brudermanns B
    Aktuelle Urol; 2007 Jan; 38(1):1-2. PubMed ID: 17290323
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
    Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
    BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.